RNA-diethylstilbestrol interaction studied by Fourier transform infrared difference spectroscopy

Area of Science:

• Biochemistry
• Molecular Biology
• Spectroscopy

Background:

• Diethylstilbestrol (DES) is a known human and animal carcinogen.
• Understanding drug-RNA interactions is crucial for drug development and toxicology.
• Yeast RNA serves as a model system for studying drug-nucleic acid interactions.

Purpose of the Study:

• To investigate the binding mode and interaction of DES with yeast RNA.
• To determine the binding constant and sequence selectivity of DES-RNA complexes.
• To analyze the effect of DES on RNA secondary structure using spectroscopic methods.

Main Methods:

• Fourier transform infrared (FTIR) difference spectroscopy was employed.
• Drug/RNA-phosphate molar ratios ranged from 1/80 to 1/2.
• Analysis focused on drug binding mode, binding constant, sequence selectivity, and RNA structure.

Main Results:

• At low DES concentrations, intercalation occurs through base pairs (Gua-Cyt, Ade-Urd) with minor external backbone PO2 interaction.
• DES exhibits a binding constant of approximately 8.5 x 10(4) M-1, indicating weaker intercalation than reference dyes.
• High DES concentrations lead to partial helix destabilization without altering overall RNA conformation.

Conclusions:

• DES interacts with yeast RNA via intercalation and external binding depending on concentration.
• The binding affinity of DES for RNA is moderate, suggesting potential for specific interactions.
• DES complexation with RNA results in structural changes, including helix destabilization, which may relate to its carcinogenic properties.